Iga Swiatek accepts one-month ban after testing positive for trimetazidine

World No 2 deemed her level of fault ‘at the lowest end’.
ONE MONTH BAN: Iga Swiatek, the world No 2 women’s tennis player, has received a one-month ban after testing positive for the banned substance trimetazidine (TMZ) in August 2024.

ONE MONTH BAN: Iga Swiatek, the world No 2 women’s tennis player, has received a one-month ban after testing positive for the banned substance trimetazidine (TMZ) in August 2024.

Iga Swiatek, the world No 2 women’s tennis player, has received a one-month ban after testing positive for the banned substance trimetazidine (TMZ) in August 2024.

In a statement on Thursday, the International Tennis Integrity Agency, which governs the tennis anti-doping programme, ruled that Swiatek’s anti-doping rule violation was not intentional and that she bore no significant fault or negligence for the positive test on “the lowest end of the range” and they imposed a one month ban.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Sport

Newsletter

Sign up to our daily sports bulletin, delivered straight to your inbox at 5pm. Subscribers also receive an exclusive email from our sports desk editors every Friday evening looking forward to the weekend's sporting action.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited